Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness

Status Completed

Clinical Trial Summary

This study is to evaluate the efficacy and safety of compound danshen dripping pills in preventing and treating acute mountain sickness.

Clinical Trial Description

Compound danshen dripping pills is mainly used for the treatment and prevention of coronary heart disease and high-risk groups ,consists of Danshen (Radix Salviae Miltiorrhizae), Sanqi (Radix Notoginseng) and borneol.Danshen is the main drug efficacy of stasis, nourishing the nerves.Pharmacological studies have shown that Danshen can improve the oxygen carrying capacity of blood, increase oxygen supply to vital organs, effectively reduce hypoxia-induced heart and other vital organs, brain and kidney damage. Danshen can activate the fibrinolytic system, reduce blood viscosity, clear the microcirculation, promote blood circulation, increasing the amount of tissue oxygen by inhibiting platelet aggregation.This study is being conducted to evaluate the efficacy and safety of compound danshen dripping pills in preventing and treating acute mountain sickness, when compared with placebo. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03270787
Study type	Interventional
Source	Tasly Pharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	June 24, 2016
Completion date	July 13, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04111263` - Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude	N/A
Completed	`NCT01842906` - Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID)	N/A
Completed	`NCT01536288` - Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness	Phase 2
Completed	`NCT00326703` - Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort	N/A
Completed	`NCT06310642` - Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness	Phase 4
Not yet recruiting	`NCT06393998` - CO2 Supplement for Treatment of Acute Mountain Sickness	N/A
Completed	`NCT03561675` - Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years	Phase 4
Completed	`NCT00559832` - Prevention of Acute Mountain Sickness by Intermittent Hypoxia	N/A
Completed	`NCT01436383` - Oxidative Stress in Hypobaric Hypoxia	N/A
Completed	`NCT00603122` - Acclimatization Mechanisms During Ascent to 7500m	N/A
Completed	`NCT00627965` - Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness	Phase 4
Completed	`NCT00664001` - Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness	Phase 3
Not yet recruiting	`NCT06145113` - The Effect of Continuous Positive Pressure Ventilation on Symptoms of Acute Mountain Sickness	N/A
Recruiting	`NCT05733338` - The Effects of Intermittent Hypoxia on Acute Hypoxic Injury	N/A
Completed	`NCT01522326` - Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness	N/A
Completed	`NCT02811016` - Inhaled Budesonide and Acute Mountain Sickness	Phase 1
Recruiting	`NCT00886912` - Training in Hypoxia to Prevent Acute Mountain Sickness	N/A
Terminated	`NCT03956472` - Alternative Treatments in Acute Mountain Sickness	N/A
Recruiting	`NCT03621410` - T89 in Prevention and Treatment of Acute Mountain Sickness (AMS) During Rapid Ascent	Phase 2
Active, not recruiting	`NCT01565603` - Sleep and Cerebral Responses to High Altitude	N/A